SR

Sangita Raje

Active Director Director DIN 10627701
DIN 10627701 First appointment May 2024 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sangita Raje

Data last updated:

Sangita Raje is a Director at Pharmace Research Laboratory Private Limited (since 2024). The company operates in Business Services.

DIN 10627701
Primary Designation Director
Industry Business Services
First Appointment 15 May 2024
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director15 May 20242023Active

Directorship timeline

Open interactive timeline →
Pharmace Research Laboratory Private Limited
Premium access

Shareholding and investment profile for Sangita Raje

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sangita Raje

Sangita Raje currently holds 1 directorship: Pharmace Research Laboratory Private Limited (Director, since 15 May 2024).

Sangita Raje was first appointed on 15 May 2024 as Director at Pharmace Research Laboratory Private Limited.

The current boards of Sangita Raje's companies include Arpit Harshad Patwari (Pharmace Research Laboratory Private Limited), Kailash Parmar (Pharmace Research Laboratory Private Limited), Paresh Narendrakumar Jhurmarwala (Pharmace Research Laboratory Private Limited), Rajkumar Jayeshkumar Solanki (Pharmace Research Laboratory Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available